Phase I/II Study of T‐DM1 Alone Versus T‐DM1 and Metronomic Temozolomide in Secondary Prevention of HER2‐Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery. Here, ERBB2 is linked to breast cancer.